一个机器学习框架来对轻度认知障碍的痴呆风险进行分类:来自韩国全基因组关联研究队列的证据
Myeongji Cho1, Hyo-Jeong Ban2, Hye Ryeong Nam1
1Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, 28159, Republic of Korea.
Alzheimer's research & therapy
|November 11, 2025
概括
这项研究开发了机器学习模型,使用遗传数据预测轻度认知障碍 (MCI) 患者的痴呆风险. 研究结果表明,基于SNP的机器学习分层是可行的,用于韩国人群的个性化风险评估.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,在早期检测方面存在挑战.
- 轻度认知障碍 (MCI) 通常在AD之前,每年有显著的痴呆症进展率.
- 全基因组关联研究 (GWAS) 已经确定单核酸多态 (SNP) 作为AD发病的关键遗传因素.
研究的目的:
- 开发和评估用于将MCI患者分为痴呆症进展高风险和低风险组的预测模型.
- 利用SNP芯片数据和机器学习 (ML) 算法用于痴呆风险预测.
- 评估在韩国MCI群体中基于SNP的ML分层的可行性.
主要方法:
- 对来自生物银行"针对阿尔茨海默氏症慢性脑血管疾病的创新研究"的韩国队列进行了GWAS,以确定与痴呆症相关的SNP.
- 训练了6个ML算法 (RF,KNN,ANN,SVM,XGBoost,LightGBM) 使用已识别的SNP来预测痴呆风险.
- 开发了使用不同SNP子集的三个预测模型,并使用AUC和PR-AUC评估性能,并预先指定值.
主要成果:
- 增强模型,特别是XGBoost (模型3),在交叉验证中表现出强的表现 (AUC=0.881,PR-AUC=0.924).
- 概率输出得到了良好的校准,显示了预测和观察到的风险之间的良好一致.
- 时间验证显示,在预测的高风险群体中,事件的歧视是适度的,但持续丰富,具有高灵敏度和F1-max值以下的NPV.
结论:
- 将遗传数据与ML集成为个性化痴呆风险评估提供了潜力.
- 基于SNP的ML分层显示在韩国MCI人群中可行性,尽管在时间验证中表现不佳.
- 进一步的研究可以完善这些模型,以改善痴呆症的早期发现和干预策略.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.痴呆症的风险 痴呆症的风险在GWAS中,GWAS就是GWAS.机器学习是机器学习.轻度认知障碍 轻度认知障碍预测模型是一个预测模型.在SNP中,SNP是SNP.更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.6K
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.7K
相关概念视频
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Dementia
503
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
503
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
